세계의 저온 플라즈마 시장 : 산업별, 용도별, 제도별, 지역별 - 예측(-2029년)

The global Cold Plasma market is projected to reach USD 3.66 billion by 2029 from USD 2.17 billion in 2024, at a CAGR of 11.0% during the forecast period. The rapid growth and adoption of cold plasma across various industries such as medical, food, electronics etc. catering to wider applications with improved benefits, growing focus on sustaibility, rise in the geriatric population globally and the significant rise in the patients with chronic wound conditions and cancer are expected to boost the demand for cold plasma market. Moreover, gradual rise in utilization of cold plasma due to improved awareness and benefits among various industries is likely to support the market growth. Advancements in cold plasma technology, new product launches, investments in R&D, and initiatives to enhance the accessibility and awareness of cold plasma is anticipated to fuel the market growth.

"The polymer & plastic industry segment of cold plasma market to register highest share during the forecast period."

Based on the cold plasma market, the polymer & plastic industry cold plasma segment is anticipated to capture highest share during forecast period. The cold plasma market is experiencing growth in the plastic and polymer industry due to its ability to enhance surface properties like adhesion, wettability, and barrier resistance. This technology supports applications in coatings and packaging while offering a non-thermal, eco-friendly alternative that minimizes the use of harsh chemicals. As industries increasingly prioritize product performance and sustainability, alongside a focus on innovation and customization, the adoption of cold plasma technology is expected to accelerate in polymer & plastic industry.

"The surface treatment & activation segment of application segment to capture the largest market share of cold plasma market."

Based on application, the surface treatment & activation segment registered the highest share and expected to grow at higher pace during forecast period. This can be attributed due to its effectiveness in enhancing adhesion and wettability. Its non-thermal, eco-friendly approach appeals to various industries, driving increased adoption and innovation in applications are boosting the adoption of cold plasma technology in this application.Moreover, advancements in cold plasma technology are enabling more efficient and customizable applications, further propelling its adoption.

"North America accounted for the largest share of the cold plasma market by region."

The global cold plasma market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for cold plasma , whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

The largest share of North America is attributed to the high disease burden of chronic wound cases and cancer burden disease contributing to a larger pool of patients requiring cold plasma products. The presence of numerous potential market giants and omproved awareness in the region is likely to promote the growth of cold plasma market in North America.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3- 25%
• By Designation: Directors-25%, Managers-50% and Others-25%
• By Region: North America-35%, Europe-30%, Asia Pacific-15% and RoW-20%

The major players operating in the cold plasma market market are Apyx Medical (US), Nordson Corporation (US), Adtec Plasma Technology Co. Ltd. (Japan), P2i Ltd.(UK), Relyon Plasma GmbH (Germany), Henniker Plasma (UK), Enercon Industries Corporation (US), AcXys Plasma Technologies (France), Plasmatreat GmbH (Germany), Tantec A/S (Denmark), Europlasma NV (Belgium), Thierry Corp. (Germany), Surfx Technologies, LLC (US), SOFTAL Corona & Plasma GmbH (Germany), Coating Plasma Innovation (France), Ferrarini & Benelli (Italy), Neoplas GmbH (Germany), Terraplasma GmbH (Germany), Molecular Plasma Group SA (Germany), and CINOGY Technologies GmbH (Germany)

Research Coverage

This report studies the cold plasma market based on industry, application, regime and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

• Analysis of Key divers (increased benefits and wider application, rising use in wound healing , growing applications in cancer and infectious disease, technological advancements), restraints (high capital investments), Opportunities (emerging markets, growing sustainability across industries) , Challenge (limited commercialization and awareness, limited key players presence in emerging economies)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the cold plasma market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the cold plasma market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the cold plasma market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary sources
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET RANKING ANALYSIS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 COLD PLASMA MARKET OVERVIEW
• 4.2 ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY
• 4.3 COLD PLASMA MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increased benefits and wider industrial applications
    • 5.2.1.2 Increasing use in wound healing
    • 5.2.1.3 Growing applications in cancer and infectious disease treatment
    • 5.2.1.4 Technological advancements and new product launches
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High capital investments
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing focus on sustainability in various industries
    • 5.2.3.2 Growth opportunities in emerging countries
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Limited commercialization and awareness of cold plasma
    • 5.2.4.2 Limited presence of key players in developing countries
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Dielectric barrier discharge (DBD)
    • 5.3.1.2 Atmospheric pressure plasma jet (APPJ)
  • 5.3.2 COMPLEMENTARY TECHNOLOGIES
    • 5.3.2.1 Ultraviolet (UV)
    • 5.3.2.2 Electrostatic spraying
  • 5.3.3 ADJACENT TECHNOLOGIES
    • 5.3.3.1 Radiofrequency (RF) plasma
• 5.4 INDUSTRY TRENDS
  • 5.4.1 INCREASING ADOPTION IN HEALTHCARE
  • 5.4.2 FOOD SAFETY AND PRESERVATION
  • 5.4.3 GROWTH IN TEXTILE AND MATERIAL PROCESSING
  • 5.4.4 FOCUS ON SUSTAINABLE SOLUTIONS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 TRADE ANALYSIS
  • 5.6.1 IMPORT DATA
  • 5.6.2 EXPORT DATA
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 BARGAINING POWER OF SUPPLIERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY LANDSCAPE
    • 5.8.1.1 North America
      • 5.8.1.1.1 US
      • 5.8.1.1.2 Canada
    • 5.8.1.2 Europe
    • 5.8.1.3 Asia Pacific
      • 5.8.1.3.1 India
      • 5.8.1.3.2 China
      • 5.8.1.3.3 Japan
    • 5.8.1.4 Latin America
      • 5.8.1.4.1 Brazil
      • 5.8.1.4.2 Mexico
    • 5.8.1.5 Middle East
    • 5.8.1.6 Africa
  • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.9 PATENT ANALYSIS
  • 5.9.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.10 PRICING ANALYSIS
  • 5.10.1 AVERAGE SELLING PRICE TREND OF COLD PLASMA SYSTEMS, BY KEY PLAYER
  • 5.10.2 INDICATIVE PRICING ANALYSIS OF COLD PLASMA SYSTEMS, BY REGION
• 5.11 KEY CONFERENCES & EVENTS, 2024-2025
• 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 BUYING CRITERIA
• 5.13 ECOSYSTEM ANALYSIS
• 5.14 CASE STUDY ANALYSIS
• 5.15 REIMBURSEMENT ANALYSIS
• 5.16 UNMET NEEDS
• 5.17 VALUE CHAIN ANALYSIS
• 5.18 END-USER EXPECTATIONS
• 5.19 IMPACT AI ON COLD PLASMA MARKET
• 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.21 INVESTMENT & FUNDING SCENARIO

6 COLD PLASMA MARKET, BY INDUSTRY

• 6.1 INTRODUCTION
• 6.2 POLYMER & PLASTIC INDUSTRY
  • 6.2.1 GROWING POPULARITY OF COLD PLASMA AS SURFACE MODIFICATION TECHNOLOGY TO BOOST MARKET GROWTH
• 6.3 TEXTILE INDUSTRY
  • 6.3.1 ADVANTAGES OF COLD PLASMA TECHNOLOGY SUCH AS COST SAVINGS FOR TEXTILE PROCESSING TO DRIVE DEMAND
• 6.4 ELECTRONICS & SEMICONDUCTORS INDUSTRY
  • 6.4.1 INCREASING USE OF COLD PLASMA IN SEMICONDUCTOR & ELECTRONICS MANUFACTURING TO FUEL GROWTH
• 6.5 FOOD & AGRICULTURE INDUSTRY
  • 6.5.1 ABILITY OF COLD PLASMA TO ENHANCE SEED GERMINATION AND AGRICULTURAL PRODUCTIVITY TO FUEL GROWTH
• 6.6 MEDICAL INDUSTRY
  • 6.6.1 RISING PREVALENCE OF CHRONIC WOUNDS AND SURGICAL-SITE INFECTIONS TO BOOST DEMAND
• 6.7 COSMETIC INDUSTRY
  • 6.7.1 SHIFT TOWARD MINIMALLY INVASIVE COSMETIC PROCEDURES TO SUPPORT MARKET GROWTH
• 6.8 OTHER INDUSTRIES

7 COLD PLASMA MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 SURFACE TREATMENT & ACTIVATION
  • 7.2.1 SURFACE TREATMENT APPLICATIONS TO DOMINATE POLYMER & PLASTIC INDUSTRY
• 7.3 COATING & THIN-FILM DEPOSITION
  • 7.3.1 ABILITY OF PLASMA TO IMPROVE PERFORMANCE AND SAFETY OF ELECTRONICS & SEMICONDUCTORS TO DRIVE GROWTH
• 7.4 PRINTING
  • 7.4.1 INCREASING USE OF COLD PLASMA AS EFFECTIVE ALTERNATIVE METHOD TO WET PROCESSING TO AID MARKET GROWTH
• 7.5 SURFACE CLEANING & DECONTAMINATION
  • 7.5.1 SIGNIFICANT ADVANTAGES OF COLD PLASMA IN PACKAGING DECONTAMINATION TO SUPPORT GROWTH
• 7.6 WOUND HEALING
  • 7.6.1 MAJOR APPLICATIONS OF COLD PLASMA IN MEDICAL INDUSTRY TO FAVOR MARKET
• 7.7 SURFACE ETCHING
  • 7.7.1 SIGNIFICANT USE IN SEMICONDUCTOR INDUSTRY FOR PRINTING INTEGRATED CIRCUIT BOARDS TO BOOST MARKET
• 7.8 SURGICAL
  • 7.8.1 WIDER APPLICATIONS OF COLD PLASMA IN SURGICAL TREATMENTS TO DRIVE MARKET
• 7.9 AESTHETIC PROCEDURES
  • 7.9.1 GROWING NUMBER OF AESTHETIC PROCEDURES TO DRIVE MARKET GROWTH
• 7.10 OTHER APPLICATIONS

8 COLD PLASMA MARKET, BY REGIME

• 8.1 INTRODUCTION
• 8.2 ATMOSPHERIC COLD PLASMA
  • 8.2.1 COST-EFFECTIVENESS OF ATMOSPHERIC COLD PLASMA TO DRIVE GROWTH
• 8.3 LOW-PRESSURE COLD PLASMA
  • 8.3.1 ADVANTAGES SUCH AS BACTERICIDAL ACTIVITY AND MINIMAL SURFACE ABLATION TO DRIVE DEMAND

9 COLD PLASMA MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American cold plasma market
  • 9.2.3 CANADA
    • 9.2.3.1 Rising cancer cases to drive market growth in Canada
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Germany to hold largest share of market in Europe
  • 9.3.3 FRANCE
    • 9.3.3.1 Growth in electronics & semiconductors industry to support market growth
  • 9.3.4 UK
    • 9.3.4.1 Rising funding for R&D and favorable investment scenario to aid growth
  • 9.3.5 ITALY
    • 9.3.5.1 Growing healthcare investment to support market growth
  • 9.3.6 SPAIN
    • 9.3.6.1 Rising prevalence of cancer to support market in Spain
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Rising cancer incidence and growing geriatric population to fuel growth
  • 9.4.3 CHINA
    • 9.4.3.1 China to register highest growth in global cold plasma market
  • 9.4.4 INDIA
    • 9.4.4.1 Significant R&D spending in country to drive market
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Rising prevalence of cancer and government support to fuel market
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Increasing benefits and awareness of cold plasma to boost market demand
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Brazil to dominate cold plasma market in Latin America
  • 9.5.3 MEXICO
    • 9.5.3.1 Improving healthcare to aid market growth
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 High healthcare spending capacity and industrial demands to propel growth
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN, JANUARY 2021-JANUARY 2025
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COLD PLASMA MARKET
• 10.3 REVENUE ANALYSIS, 2019-2023
• 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.4.1 RANKING OF KEY MARKET PLAYERS
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Industry footprint
    • 10.5.5.3 Regime footprint
    • 10.5.5.4 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 10.7 BRAND/PRODUCT COMPARISON
• 10.8 R&D ASSESSMENT OF KEY PLAYERS
• 10.9 COMPANY VALUATION & FINANCIAL METRICS
  • 10.9.1 FINANCIAL METRICS
  • 10.9.2 COMPANY VALUATION
• 10.10 COMPETITIVE SCENARIO
  • 10.10.1 PRODUCT LAUNCHES & APPROVALS
  • 10.10.2 DEALS
  • 10.10.3 EXPANSIONS
  • 10.10.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 NORDSON CORPORATION
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 ADTEC PLASMA TECHNOLOGY CO., LTD.
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches
      • 11.1.2.3.2 Expansions
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 PLASMATREAT GMBH
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches & approvals
      • 11.1.3.3.2 Deals
      • 11.1.3.3.3 Expansions
      • 11.1.3.3.4 Other developments
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 APYX MEDICAL
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches & approvals
      • 11.1.4.3.2 Other developments
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 RELYON PLASMA GMBH
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Deals
      • 11.1.5.3.2 Other developments
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 P2I LTD.
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
  • 11.1.7 HENNIKER PLASMA
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
  • 11.1.8 ENERCON INDUSTRIES CORPORATION
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product launches & enhancements
      • 11.1.8.3.2 Expansions
  • 11.1.9 ACXYS PLASMA TECHNOLOGIES
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 TANTEC A/S
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Deals
• 11.2 OTHER PLAYERS
  • 11.2.1 EUROPLASMA NV
  • 11.2.2 THIERRY CORP.
  • 11.2.3 SURFX TECHNOLOGIES, LLC
  • 11.2.4 SOFTAL CORONA & PLASMA GMBH
  • 11.2.5 COATING PLASMA INNOVATION
  • 11.2.6 FERRARINI & BENELLI SRL
  • 11.2.7 NEOPLAS MED GMBH
  • 11.2.8 TERRAPLASMA GMBH
  • 11.2.9 MOLECULAR PLASMA GROUP
  • 11.2.10 CINOGY TECHNOLOGIES GMBH
  • 11.2.11 US MEDICAL INNOVATIONS
  • 11.2.12 LEAFLIFE TECHNOLOGY
  • 11.2.13 PLASMAWISE
  • 11.2.14 PHASERTEK ENVIRONMENTAL LTD.
  • 11.2.15 KEYLINK

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS